WGO Practice Guideline - Hepatocellular carcinoma (HCC): a global perspective
Title: Hepatocellular carcinoma (HCC): a global perspective - November 2009
Introduction
More than 600,000 people die from hepatocellular carcinoma (HCC) each year. Worldwide research on the disease needs to be intensified in both the medical and pharmaceutical fields, especially with a focus on providing help to areas where resources are limited.
Language Versions
View this Guideline in your chosen language - PDF file format
Review Team
- Peter Ferenci (chair) (Austria)
- Michael Fried (Switzerland)
- Douglas Labrecque (USA)
- J. Bruix (Spain)
- M. Sherman (Canada)
- M. Omata (Japan)
- J. Heathcote (Canada)
- T. Piratsivuth (Thailand)
- Mike Kew (South Africa)
- Jesse A. Otegbayo (Nigeria)
- S.S. Zheng (China)
- S. Sarin (India)
- S. Hamid (Pakistan)
- Salma Barakat Modawi (Sudan)
- Wolfgang Fleig (Germany)
- Suliman Fedail (Sudan)
- Alan Thomson (Canada)
- Aamir Khan (Pakistan)
- Peter Malfertheiner (Germany)
- George Lau (Hong Kong)
- F.J. Carillo (Brazil)
- Justus Krabshuis (France)
- Anton Le Mair (The Netherlands)
Bookmark with:
What are these?